holoride USD Price: Quote, Market Cap, Forecast & News (RIDEUSD)

Iris Energy Faces Lowered FY2025 Earnings Outlook Amid Mixed Analyst Ratings

May 19, 2025

Roth Capital has reduced its FY2025 earnings per share estimate for Iris Energy, now expecting a $0.04 loss per share, down from an earlier forecast of $0.18 in profit. Despite this, the company retains a consensus "Buy" rating, with institutional investors holding over 41% of shares.

PATH Scholarship Program Nears Application Deadline for U.S. Institutions

May 7, 2025

U.S. colleges have until May 23 to apply for the 2025 PATH Scholarship Program, which offers block grants of $10,000 to $25,000 for students in financial distress. The program, now in its sixth year, aims to support students facing hardship, with individual awards up to $1,500 available.

GAAGX GMO Alternative Allocation Fund Dips Slightly as Investors Watch Peers

May 22, 2025

The GAAGX GMO Alternative Allocation Fund Class I ETF closed at $17.59, slipping 0.23% in the latest session. Peer funds, including GAAVX and VMEPX, saw mixed performance, with VMEPX up 1.08%. The fund continues to attract attention from investors comparing alternative allocation strategies.

Go Deeper

Related

Go Deeper